Otofarma S.p.A. Logo

Otofarma S.p.A.

Provides tailored hearing solutions and remote diagnostics through a partner pharmacy network.

OTO | Euronext Growth

Overview

Corporate Details

ISIN(s):
IT0005663361
LEI:
815600FED560ACA5D783
Country:
Italy
Address:
N/A
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

Otofarma S.p.A. is an Italian company that specializes in the design, manufacture, and marketing of custom hearing aids and related accessories. The company provides personalized otoacoustic medical devices, including in-the-ear (Endoauricular) and behind-the-ear (Retroauricular) models, to address hearing loss. A key part of its service offering is Teleaudiology, a telemedicine platform that facilitates remote otoscopic and audiometric examinations through a network of partner pharmacies. This allows specialists to prescribe and create precisely tailored hearing solutions for patients based on detailed diagnostic data. The company emphasizes its focus on comfort, discretion, and delivering a natural sound experience for its users.

Social Media

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Otofarma S.p.A. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-08 17:49
Share Issue/Capital Change
OTOFARMA: announcement of change in share capital following full exercise of gr…
English 353.3 KB
2025-09-08 17:47
Share Issue/Capital Change
OTOFARMA: comunicazione di avvenuta variazione del capitale sociale a seguito d…
Italian 355.3 KB
2025-09-05 18:03
Director's Dealing
Internal Dealing
Italian 88.5 KB
2025-09-02 18:17
Regulatory News Service
OTOFARMA: full exercise of the Greenshoe Option
Italian 320.7 KB
2025-09-02 18:14
Regulatory News Service
OTOFARMA: esercizio integrale dell’opzione greenshoe
Italian 347.4 KB

Automate Your Workflow. Get a real-time feed of all Otofarma S.p.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Otofarma S.p.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Develops implantable tech for localized chemotherapy delivery directly into solid tumors.
Virgin Islands (British) N/A
CS Medica A/S Logo
Develops patented, CBD-infused medical devices for pain, autoimmune, and stress relief.
Denmark CSMED
Cytori Cell Research Institute,Inc. Logo
Develops devices and cell therapies using a patient's fat tissue to repair injury and treat disease.
Japan 3750
DAIKEN MEDICAL CO.,LTD Logo
Develops medical devices for anesthesia, infection control, and aspiration systems globally.
Japan 7775
Danish Aerospace Company A/S Logo
Develops advanced medical and exercise equipment for astronauts and space applications.
Denmark DAC
Demant Logo
A global leader in hearing aids, diagnostics, and care for professionals and end-users.
Denmark DEMANT
Deversify Health AB Logo
Developed mobile breathalyzers and apps for metabolic health for consumers, businesses & healthcare.
Sweden DEV
Diagonal Bio AB Logo
Developing a platform for ultra-fast, PCR-accurate diagnostics of infectious diseases.
Sweden DIABIO
Dignitana AB Logo
Develops a scalp cooling system for cancer patients to reduce hair loss during chemotherapy.
Sweden DIGN
Draegerwerk AG & Co. KGaA Logo
Develops life-saving medical and safety technology for hospitals and industry.
Germany DRW8

Talk to a Data Expert

Have a question? We'll get back to you promptly.